Husain Matloob
Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Results Probl Cell Differ. 2025;75:329-361. doi: 10.1007/978-3-031-91459-1_12.
Viruses are acellular organisms and part of our ecosystem but exist at the interface of living and non-living. Furthermore, viruses are obligate intracellular parasites hence require the machinery of other organisms to multiply. Consequently, most viral infections result into a viral disease. Broadly, viruses cause two types of infection-acute and persistent (latent and chronic), in humans and other mammals that could lead to various lethal and non-lethal viral diseases. Acetylation is now known to be a ubiquitous protein (and nucleic acid) modification and is critical for cellular metabolism. An imbalance in acetylation has been associated with various cancers and diseases in humans. Likewise, the association of acetylation with viral infection and disease was observed soon after its discovery in twentieth century. Now, the literature accumulated in this space shows that acetylation promotes the infection of many viruses causing both acute and persistent infections. Furthermore, reduction in the acetylation level reduces viral clearance from the host and promotes viral persistency. The latter can be interrupted by increasing the acetylation level by using deacetylase inhibitors. Indeed, this approach has become a therapeutic tool to treat and clear the persistent viral infections as well as boost the oncolytic virus-mediated cancer therapy.
病毒是无细胞生物,是我们生态系统的一部分,但存在于生物与非生物的界面。此外,病毒是专性细胞内寄生虫,因此需要其他生物体的机制来繁殖。因此,大多数病毒感染会导致病毒性疾病。广义而言,病毒在人类和其他哺乳动物中会引起两种类型的感染——急性感染和持续性(潜伏性和慢性)感染,这可能导致各种致命和非致命的病毒性疾病。现在已知乙酰化是一种普遍存在的蛋白质(和核酸)修饰,对细胞代谢至关重要。乙酰化失衡与人类的各种癌症和疾病有关。同样,在20世纪发现乙酰化后不久,就观察到了它与病毒感染和疾病的关联。现在,这个领域积累的文献表明,乙酰化促进了许多病毒的感染,导致急性和持续性感染。此外,乙酰化水平的降低会减少病毒从宿主中的清除,并促进病毒的持续性。通过使用去乙酰化酶抑制剂提高乙酰化水平可以中断后者。事实上,这种方法已成为治疗和清除持续性病毒感染以及增强溶瘤病毒介导的癌症治疗的一种治疗工具。